Milestone Pharmaceuticals Ownership 2024 | Who Owns Milestone Pharmaceuticals Now?
Institutional Ownership
60.13%
Insider Ownership
0.69%
Retail Ownership
39.18%
Institutional Holders
40.00
Milestone Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 9.91% | 0.00% | 4,971,344 | - | - | 6,562,174 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 6.49% | 0.07% | 3,256,102 | - | - | 4,298,055 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 5.48% | 0.00% | 2,749,930 | -105,682 | -3.70% | 3,657,407 | Jun 30, 2024 |
| ALTA FUNDAMENTAL ADVISERS LLC | 5.30% | 1.11% | 2,658,589 | 287,300 | 12.12% | 3,509,337 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 4.67% | 5.63% | 2,340,207 | 40,000 | 1.74% | 3,089,073 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 3.99% | 0.05% | 2,000,000 | - | - | 2,640,000 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 3.49% | 0.14% | 1,750,000 | - | - | 2,310,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.70% | 0.00% | 1,353,067 | - | - | 1,786,048 | Jun 30, 2024 |
| BLEICHROEDER LP | 2.64% | 0.52% | 1,326,085 | - | - | 1,750,432 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.47% | 1.50% | 1,239,199 | -223,097 | -15.26% | 1,635,743 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 2.20% | 1.04% | 1,102,895 | 496,750 | 81.95% | 1,455,821 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 2.02% | 0.55% | 1,012,368 | -200,514 | -16.53% | 1,336,326 | Jun 30, 2024 |
| MORGAN STANLEY | 1.65% | 0.00% | 828,654 | 8,826 | 1.08% | 1,093,823 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.93% | 0.11% | 466,019 | - | - | 619,806 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.62% | 0.02% | 309,007 | - | - | 407,889 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.40% | 0.05% | 202,460 | - | - | 267,247 | Jun 30, 2024 |
| ANCORA ADVISORS, LLC | 0.12% | 0.00% | 60,000 | - | - | 79,200 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.12% | - | 59,523 | 7,690 | 14.84% | 78,570 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.11% | 0.00% | 54,684 | 54,684 | 100.00% | 72,730 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.08% | - | 39,450 | - | - | 52,404 | Jun 30, 2024 |
Milestone Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 9.91% of the company's total share outstanding, currently valued at $6.56M. The top 10 institutional shareholders own together 47.14% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LION POINT CAPITAL, LP | 4.67% | 5.63% | 2,340,207 | 40,000 | 1.74% | 3,089,073 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.47% | 1.50% | 1,239,199 | -223,097 | -15.26% | 1,635,743 | Jun 30, 2024 |
| ALTA FUNDAMENTAL ADVISERS LLC | 5.30% | 1.11% | 2,658,589 | 287,300 | 12.12% | 3,509,337 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 2.20% | 1.04% | 1,102,895 | 496,750 | 81.95% | 1,455,821 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 2.02% | 0.55% | 1,012,368 | -200,514 | -16.53% | 1,336,326 | Jun 30, 2024 |
| BLEICHROEDER LP | 2.64% | 0.52% | 1,326,085 | - | - | 1,750,432 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 3.49% | 0.14% | 1,750,000 | - | - | 2,310,000 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.93% | 0.11% | 466,019 | - | - | 619,806 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 6.49% | 0.07% | 3,256,102 | - | - | 4,298,055 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 3.99% | 0.05% | 2,000,000 | - | - | 2,640,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.40% | 0.05% | 202,460 | - | - | 267,247 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.62% | 0.02% | 309,007 | - | - | 407,889 | Jun 30, 2024 |
| BETA WEALTH GROUP, INC. | 0.03% | 0.01% | 14,127 | - | - | 18,648 | Jun 30, 2024 |
| CLEAR CREEK FINANCIAL MANAGEMENT, LLC | 0.04% | 0.00% | 19,500 | -5,500 | -22.00% | 25,740 | Jun 30, 2024 |
| ANCORA ADVISORS, LLC | 0.12% | 0.00% | 60,000 | - | - | 79,200 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 5.48% | 0.00% | 2,749,930 | -105,682 | -3.70% | 3,657,407 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.06% | 0.00% | 30,779 | - | - | 40,628 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.06% | 0.00% | 27,991 | 27,991 | 100.00% | 36,948 | Jun 30, 2024 |
| VALEO FINANCIAL ADVISORS, LLC | 0.02% | 0.00% | 10,000 | - | - | 13,200 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.70% | 0.00% | 1,353,067 | - | - | 1,786,048 | Jun 30, 2024 |
The largest Milestone Pharmaceuticals shareholder by % of total assets is LION POINT CAPITAL, LP. The company owns 2.34M shares of Milestone Pharmaceuticals (MIST), representing 5.63% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 2.20% | 1.04% | 1,102,895 | 496,750 | 81.95% | 1,455,821 | Jun 30, 2024 |
| ALTA FUNDAMENTAL ADVISERS LLC | 5.30% | 1.11% | 2,658,589 | 287,300 | 12.12% | 3,509,337 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.11% | 0.00% | 54,684 | 54,684 | 100.00% | 72,730 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 4.67% | 5.63% | 2,340,207 | 40,000 | 1.74% | 3,089,073 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.06% | 0.00% | 27,991 | 27,991 | 100.00% | 36,948 | Jun 30, 2024 |
| MORGAN STANLEY | 1.65% | 0.00% | 828,654 | 8,826 | 1.08% | 1,093,823 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.05% | - | 24,600 | 7,700 | 45.56% | 32,718 | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.12% | - | 59,523 | 7,690 | 14.84% | 78,570 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 1,191 | 1,191 | 100.00% | 1,000 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 1,070 | 1,070 | 100.00% | 1,412 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 6,500 | 500 | 8.33% | 8,580 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.00% | - | 194 | - | - | 258 | Jun 30, 2024 |
| STATE STREET CORP | 0.04% | - | 18,923 | - | - | 25,168,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.04% | - | 17,576 | - | - | 23,376 | Jun 30, 2024 |
| NATIONAL BANK OF CANADA /FI/ | 0.01% | - | 7,100 | - | - | 9,404 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.08% | - | 39,450 | - | - | 52,404 | Jun 30, 2024 |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | 0.00% | - | 100 | - | - | 132 | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 0.02% | 0.00% | 10,500 | - | - | 13,860 | Jun 30, 2024 |
| BLACKROCK INC. | 9.91% | 0.00% | 4,971,344 | - | - | 6,562,174 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 2.70% | 0.00% | 1,353,067 | - | - | 1,786,048 | Jun 30, 2024 |
As of Jun 30 2024, Milestone Pharmaceuticals's largest institutional buyer is BML CAPITAL MANAGEMENT, LLC. The company purchased 496.75K stocks of MIST, valued at $1.46M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -650,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -273,100 | -100.00% | - | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 2.47% | 1.50% | 1,239,199 | -223,097 | -15.26% | 1,635,743 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 2.02% | 0.55% | 1,012,368 | -200,514 | -16.53% | 1,336,326 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 5.48% | 0.00% | 2,749,930 | -105,682 | -3.70% | 3,657,407 | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -13,403 | -100.00% | - | Jun 30, 2024 |
| CLEAR CREEK FINANCIAL MANAGEMENT, LLC | 0.04% | 0.00% | 19,500 | -5,500 | -22.00% | 25,740 | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -2,618 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.06% | - | 27,784 | -532 | -1.88% | 36,674,000 | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| BLEICHROEDER LP | 2.64% | 0.52% | 1,326,085 | - | - | 1,750,432 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 3.49% | 0.14% | 1,750,000 | - | - | 2,310,000 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.93% | 0.11% | 466,019 | - | - | 619,806 | Jun 30, 2024 |
| RTW INVESTMENTS, LP | 6.49% | 0.07% | 3,256,102 | - | - | 4,298,055 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 3.99% | 0.05% | 2,000,000 | - | - | 2,640,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.40% | 0.05% | 202,460 | - | - | 267,247 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 0.62% | 0.02% | 309,007 | - | - | 407,889 | Jun 30, 2024 |
| BETA WEALTH GROUP, INC. | 0.03% | 0.01% | 14,127 | - | - | 18,648 | Jun 30, 2024 |
| ANCORA ADVISORS, LLC | 0.12% | 0.00% | 60,000 | - | - | 79,200 | Jun 30, 2024 |
As of Jun 30 2024, Milestone Pharmaceuticals's biggest institutional seller is VELAN CAPITAL INVESTMENT MANAGEMENT LP. The company sold -0.65M shares of MIST, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SQUAREPOINT OPS LLC | 0.11% | 0.00% | 54,684 | 54,684 | 100.00% | 72,730 | Jun 30, 2024 |
| ATRIA INVESTMENTS, INC | 0.06% | 0.00% | 27,991 | 27,991 | 100.00% | 36,948 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 1,070 | 1,070 | 100.00% | 1,412 | Jun 30, 2024 |
Milestone Pharmaceuticals's largest new institutional shareholder by number of shares is SQUAREPOINT OPS LLC, purchased 54.68K shares, valued at $72.73K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | - | - | - | -650,000 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -500,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -273,100 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -13,403 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -2,618 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
Milestone Pharmaceuticals's largest sold out institutional shareholder by shares sold is VELAN CAPITAL INVESTMENT MANAGEMENT LP, sold -0.65M shares, valued at -, as of undefined.
Milestone Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA HEALTHCARE INVESTORS | 0.21% | 175,816 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.16% | 77,794 | - | - | Mar 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.07% | 227,013 | - | - | Mar 31, 2024 |
| BlackRock Credit Strategies Fund | 0.05% | 261,344 | 1,248 | 0.48% | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.03% | 171,156 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 8,832 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 169,500 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 18,923 | -2,688 | -12.44% | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 17,576 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 24,122 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 9,515 | - | - | Jan 31, 2024 |
| Voya MUTUAL FUNDS | 0.00% | 2,869 | - | - | Jan 31, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 229,128 | - | - | Jan 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 33,025 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 600 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,598 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 480 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 5,597 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,346 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 785 | -39,916 | -98.07% | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 9,082 | - | - | Feb 29, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 500 | - | - | Mar 31, 2024 |
Milestone Pharmaceuticals's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 175.82K shares, compromising 0.21% of its total assets.
Milestone Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 40 | -9.09% |
| 31 Mar, 24 | 44 | 4.76% |
| 31 Dec, 23 | 42 | 5.00% |
| 30 Sep, 23 | 40 | -18.37% |
| 30 Jun, 23 | 49 | -3.92% |
| 31 Mar, 23 | 51 | -13.56% |
| 31 Dec, 22 | 59 | -3.28% |
| 30 Sep, 22 | 61 | 74.29% |
| 30 Jun, 22 | 35 | 20.69% |
| 31 Mar, 22 | 29 | 16.00% |
| 31 Dec, 21 | 25 | -13.79% |
| 30 Sep, 21 | 29 | -3.33% |
| 30 Jun, 21 | 30 | -18.92% |
| 31 Mar, 21 | 37 | 12.12% |
| 31 Dec, 20 | 33 | 13.79% |
| 30 Sep, 20 | 29 | 38.10% |
| 30 Jun, 20 | 21 | 40.00% |
| 31 Mar, 20 | 15 | -37.50% |
| 31 Dec, 19 | 24 | 9.09% |
| 30 Sep, 19 | 22 | -8.33% |
| 30 Jun, 19 | 24 | - |
As of 30 Jun 24, 40 institutions are holding Milestone Pharmaceuticals's shares, representing a decrease of -9.09% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 30,157,942 | -3.81% |
| 31 Mar, 24 | 31,351,699 | 76.28% |
| 31 Dec, 23 | 17,784,737 | -8.16% |
| 30 Sep, 23 | 19,364,922 | -5.45% |
| 30 Jun, 23 | 20,480,089 | -4.80% |
| 31 Mar, 23 | 21,512,503 | -10.74% |
| 31 Dec, 22 | 24,101,633 | 9.76% |
| 30 Sep, 22 | 21,958,156 | 5.44% |
| 30 Jun, 22 | 20,825,690 | -0.94% |
| 31 Mar, 22 | 21,024,370 | 4.07% |
| 31 Dec, 21 | 20,201,417 | 1.49% |
| 30 Sep, 21 | 19,905,807 | -0.90% |
| 30 Jun, 21 | 20,087,041 | -0.63% |
| 31 Mar, 21 | 20,213,926 | -1.31% |
| 31 Dec, 20 | 20,482,274 | 33.13% |
| 30 Sep, 20 | 15,385,487 | 58.59% |
| 30 Jun, 20 | 9,701,632 | 5.11% |
| 31 Mar, 20 | 9,230,018 | -35.80% |
| 31 Dec, 19 | 14,376,981 | 10.00% |
| 30 Sep, 19 | 13,069,429 | -0.09% |
| 30 Jun, 19 | 13,080,834 | - |
Milestone Pharmaceuticals (MIST) has 30.16M shares outstanding as of 30 Jun 24, down -3.81% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 60.13% | 1.13% |
| 31 Mar, 24 | 72.99% | 4.26% |
| 31 Dec, 23 | 41.39% | 2.03% |
| 30 Sep, 23 | 45.10% | 1.97% |
| 30 Jun, 23 | 47.79% | 1.90% |
| 31 Mar, 23 | 50.20% | 1.58% |
| 31 Dec, 22 | 56.34% | 2.11% |
| 30 Sep, 22 | 51.68% | 2.13% |
| 30 Jun, 22 | 49.26% | 1.99% |
| 31 Mar, 22 | 49.77% | 2.17% |
| 31 Dec, 21 | 47.89% | 2.15% |
| 30 Sep, 21 | 47.19% | 2.03% |
| 30 Jun, 21 | 48.20% | 2.01% |
| 31 Mar, 21 | 49.00% | 1.01% |
| 31 Dec, 20 | 69.80% | 2.61% |
| 30 Sep, 20 | 51.67% | 3.33% |
| 30 Jun, 20 | 39.39% | 2.79% |
| 31 Mar, 20 | 37.60% | 0.45% |
| 31 Dec, 19 | 91.08% | 1.33% |
| 30 Sep, 19 | 82.80% | 0.84% |
| 30 Jun, 19 | 99.17% | - |
As of 30 Jun 24, Milestone Pharmaceuticals is held by 60.13% institutional shareholders, representing a 1.13% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 12 | -52.00% |
| 31 Mar, 24 | 25 | 56.25% |
| 31 Dec, 23 | 16 | 45.45% |
| 30 Sep, 23 | 11 | -52.17% |
| 30 Jun, 23 | 23 | 21.05% |
| 31 Mar, 23 | 19 | -54.76% |
| 31 Dec, 22 | 42 | 40.00% |
| 30 Sep, 22 | 30 | 172.73% |
| 30 Jun, 22 | 11 | -42.11% |
| 31 Mar, 22 | 19 | 46.15% |
| 31 Dec, 21 | 13 | 44.44% |
| 30 Sep, 21 | 9 | -25.00% |
| 30 Jun, 21 | 12 | -33.33% |
| 31 Mar, 21 | 18 | -18.18% |
| 31 Dec, 20 | 22 | 29.41% |
| 30 Sep, 20 | 17 | 30.77% |
| 30 Jun, 20 | 13 | 85.71% |
| 31 Mar, 20 | 7 | -36.36% |
| 31 Dec, 19 | 11 | 175.00% |
| 30 Sep, 19 | 4 | -83.33% |
| 30 Jun, 19 | 24 | - |
12 institutional shareholders have increased their position in MIST stock as of 30 Jun 24 compared to 25 in the previous quarter (a -52.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | 20.00% |
| 31 Mar, 24 | 5 | -50.00% |
| 31 Dec, 23 | 10 | -28.57% |
| 30 Sep, 23 | 14 | 16.67% |
| 30 Jun, 23 | 12 | -25.00% |
| 31 Mar, 23 | 16 | 100.00% |
| 31 Dec, 22 | 8 | -33.33% |
| 30 Sep, 22 | 12 | 33.33% |
| 30 Jun, 22 | 9 | 350.00% |
| 31 Mar, 22 | 2 | -33.33% |
| 31 Dec, 21 | 3 | -72.73% |
| 30 Sep, 21 | 11 | 57.14% |
| 30 Jun, 21 | 7 | -12.50% |
| 31 Mar, 21 | 8 | 33.33% |
| 31 Dec, 20 | 6 | 100.00% |
| 30 Sep, 20 | 3 | 200.00% |
| 30 Jun, 20 | 1 | -85.71% |
| 31 Mar, 20 | 7 | 40.00% |
| 31 Dec, 19 | 5 | - |
| 30 Sep, 19 | 5 | - |
| 30 Jun, 19 | - | - |
6 institutional shareholders have reduced their position in MIST stock as of 30 Jun 24 compared to 5 in the previous quarter (a 20.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 40 | -9.09% | 30,157,942 | -3.81% | 60.13% | 1.13% | 12 | -52.00% | 6 | 20.00% |
| 31 Mar, 24 | 44 | 4.76% | 31,351,699 | 76.28% | 72.99% | 4.26% | 25 | 56.25% | 5 | -50.00% |
| 31 Dec, 23 | 42 | 5.00% | 17,784,737 | -8.16% | 41.39% | 2.03% | 16 | 45.45% | 10 | -28.57% |
| 30 Sep, 23 | 40 | -18.37% | 19,364,922 | -5.45% | 45.10% | 1.97% | 11 | -52.17% | 14 | 16.67% |
| 30 Jun, 23 | 49 | -3.92% | 20,480,089 | -4.80% | 47.79% | 1.90% | 23 | 21.05% | 12 | -25.00% |
| 31 Mar, 23 | 51 | -13.56% | 21,512,503 | -10.74% | 50.20% | 1.58% | 19 | -54.76% | 16 | 100.00% |
| 31 Dec, 22 | 59 | -3.28% | 24,101,633 | 9.76% | 56.34% | 2.11% | 42 | 40.00% | 8 | -33.33% |
| 30 Sep, 22 | 61 | 74.29% | 21,958,156 | 5.44% | 51.68% | 2.13% | 30 | 172.73% | 12 | 33.33% |
| 30 Jun, 22 | 35 | 20.69% | 20,825,690 | -0.94% | 49.26% | 1.99% | 11 | -42.11% | 9 | 350.00% |
| 31 Mar, 22 | 29 | 16.00% | 21,024,370 | 4.07% | 49.77% | 2.17% | 19 | 46.15% | 2 | -33.33% |
| 31 Dec, 21 | 25 | -13.79% | 20,201,417 | 1.49% | 47.89% | 2.15% | 13 | 44.44% | 3 | -72.73% |
| 30 Sep, 21 | 29 | -3.33% | 19,905,807 | -0.90% | 47.19% | 2.03% | 9 | -25.00% | 11 | 57.14% |
| 30 Jun, 21 | 30 | -18.92% | 20,087,041 | -0.63% | 48.20% | 2.01% | 12 | -33.33% | 7 | -12.50% |
| 31 Mar, 21 | 37 | 12.12% | 20,213,926 | -1.31% | 49.00% | 1.01% | 18 | -18.18% | 8 | 33.33% |
| 31 Dec, 20 | 33 | 13.79% | 20,482,274 | 33.13% | 69.80% | 2.61% | 22 | 29.41% | 6 | 100.00% |
| 30 Sep, 20 | 29 | 38.10% | 15,385,487 | 58.59% | 51.67% | 3.33% | 17 | 30.77% | 3 | 200.00% |
| 30 Jun, 20 | 21 | 40.00% | 9,701,632 | 5.11% | 39.39% | 2.79% | 13 | 85.71% | 1 | -85.71% |
| 31 Mar, 20 | 15 | -37.50% | 9,230,018 | -35.80% | 37.60% | 0.45% | 7 | -36.36% | 7 | 40.00% |
| 31 Dec, 19 | 24 | 9.09% | 14,376,981 | 10.00% | 91.08% | 1.33% | 11 | 175.00% | 5 | - |
| 30 Sep, 19 | 22 | -8.33% | 13,069,429 | -0.09% | 82.80% | 0.84% | 4 | -83.33% | 5 | - |
| 30 Jun, 19 | 24 | - | 13,080,834 | - | 99.17% | - | 24 | - | - | - |
Milestone Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Milestone Pharmaceuticals's stock was made by Saik Andrew on Jul 17 2024, selling 80,000 shares at $1.58 per share (valued at $126.80K). The last insider buy of MIST was made by Bharucha David on Dec 05 2022, buying 7,000 shares at $4.69 per share (worth $32.83K).
Milestone Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 6 | 1 | 600.00% |
| Q4 2022 | 7 | - | - |
| Q3 2022 | 13 | 2 | 650.00% |
| Q2 2022 | 5 | 5 | 100.00% |
| Q1 2022 | 5 | - | - |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | 3 | - | - |
| Q3 2020 | 2 | 3 | 66.67% |
| Q2 2020 | 13 | 2 | 650.00% |
| Q1 2020 | 8 | - | - |
| Q4 2019 | 15 | 3 | 500.00% |
| Q3 2019 | 2 | - | - |
| Q2 2019 | 15 | 43 | 34.88% |
0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Milestone Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 7 | - | - |
| Q3 2022 | 2 | 2 | 100.00% |
| Q2 2022 | 1 | - | - |
| Q1 2022 | - | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 1 | 2 | 50.00% |
| Q2 2020 | - | - | - |
| Q1 2020 | 4 | - | - |
| Q4 2019 | 10 | 1 | 1000.00% |
| Q3 2019 | - | - | - |
| Q2 2019 | 4 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Milestone Pharmaceuticals's stocks.
Milestone Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| IVA | Inventiva S.A. |
| IKT | Inhibikase Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| SCPH | scPharmaceuticals Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| SPRO | Spero Therapeutics, Inc. |
| MCRB | Seres Therapeutics, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| ONCY | Oncolytics Biotech Inc. |
| NAMS | NewAmsterdam Pharma Company N.V. |
| DMAC | DiaMedica Therapeutics Inc. |
| NLTX | Neurogene Inc. |
| CHRS | Coherus BioSciences, Inc. |
| LIFE | aTyr Pharma, Inc. |
| CMPX | Compass Therapeutics, Inc. |
| GRTX | Galera Therapeutics, Inc. |
MIST Ownership FAQ
Who Owns Milestone Pharmaceuticals?
Milestone Pharmaceuticals is owned by institutional shareholders (60.13%), insiders (0.69%), and public (39.18%). The largest institutional shareholder of Milestone Pharmaceuticals is BLACKROCK INC. (9.91% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.21% of total shares).
Who are the major institutional shareholders of Milestone Pharmaceuticals?
Milestone Pharmaceuticals's major institutional shareholders are BLACKROCK INC., RTW INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, ALTA FUNDAMENTAL ADVISERS LLC, and LION POINT CAPITAL, LP. The top five shareholders own together 31.85% of the company's share outstanding.
How many Milestone Pharmaceuticals shareholders are there?
As of Jun 2024, there are 40 institutional shareholders of Milestone Pharmaceuticals.
What percentage of Milestone Pharmaceuticals is owned by BLACKROCK INC?
BLACKROCK INC owns 4.97M shares of Milestone Pharmaceuticals, representing 9.91% of the company's total shares outstanding, valued at $6.56M (as of Jun 2024).
What percentage of Milestone Pharmaceuticals is owned by RTW INVESTMENTS, LP?
As of Jun 2024, RTW INVESTMENTS, LP holds 3.26M shares of Milestone Pharmaceuticals (MIST), compromising 6.49% of the company, valued at $4.3M.
What percentage of Milestone Pharmaceuticals is owned by MILLENNIUM MANAGEMENT LLC?
MILLENNIUM MANAGEMENT LLC is the third largest holder of Milestone Pharmaceuticals. The company owns 2.75M of the company's shares outstanding (worth $3.66M).